A potent Nrf2 activator, hydralazine was used by Guo et al. [274] against the MPTP-induced PD model in SH-SY5Y cells and mice, resulting in significant translocation of Nrf2, as well as upregulation of the expression of its downstream antioxidant genes. The gene discussed is NFE2L2; the disease is Parkinson disease.